semaglutide gut health Taking Ozempic or Mounjaro? New research says your may be paying attention. Studies are now starting to find an association between GLP-1 medications and the development of SIBO within the first Semaglutide GLP-1 for Medical Weight

The stock is down by 49% from its peak of $72.98 last week

As the prevalence of these metabolic disorders continues to rise, the GLP-1 receptor agonist market is set for substantial growth in the coming years

Come in for a consultation to see if this program is right for you

PlexusDx's Precision Peptide Genetic Test ($298) examines GLP-1 receptor and metabolic variants to provide context for a personalized conversation with your provider

These reports documented: Severe gastroparesis requiring hospitalization and ongoing medical treatment Intestinal blockages necessitating emergency surgery Vision loss cases involving non-arteritic anterior ischemic optic neuropathy Deep vein thrombosis and other cardiovascular complications Gallbladder disease requiring surgical removal Rather than immediately updating Ozempics warning label to reflect these serious concerns, pharmaceutical companies continued aggressive marketing of the weight loss drug